Proteomic analysis of blood serum protein profiles in children with autism

Voprosy Prakticheskoi Pediatrii

Volumn 11, Issue 5, 2016, Pages 12-17

  Kaysheva, A L ^a,b   Kopylov, A T ^a   Yurov, I Y ^c,d   Vorsanova, S G ^c,d,e   Yurov, Y B ^c,d,e   Galiullin, R A ^a   Anashkina, A S ^a   Archakov, A I ^a   Ivanov, Y D ^a  

^a INSTITUTE OF BIOMEDICAL CHEMISTRY   (Russian Federation)

^b PostGenTech LLC   (Russian Federation)

^c MENTAL HEALTH RESEARCH CENTER   (Russian Federation)

^d PIROGOV RUSSIAN NATIONAL RESEARCH MEDICAL UNIVERSITY   (Russian Federation)

^e MOSCOW STATE UNIVERSITY OF PSYCHOLOGY AND EDUCATION   (Russian Federation)

Author keywords

Autism; High resolution mass spectrometry; Protein markers

Indexed keywords

EID: 85014373419     PISSN: 18177646     EISSN: 24149705     Source Type: Journal    
DOI: 10.20953/1817-7646-2016-5-12-17     Document Type: Article

References (23)

1. Prevalence of Autism Spectrum Disorders-Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008 Surveillance Summaries March 30, 2012 /61(SS03);1-19.
2. Conciatori M, Stodgell CJ, Hyman SL, O'Bara M, Militerni R, Bravaccio C, et al. Association between the HOXA1 A218G polymorphism and increased head circumference in patients with autism. Biol Psychiatry. 2004;55(4):413-9.
3. Freitag CM, Staal W, Klauck SM, Duketis E, Waltes R. Genetics of autistic disorders: review and clinical implications. Eur Child Adolesc Psychiatry. 2010;19(3):169-78.
4. Hu VW, Nguyen A, Kim KS, Steinberg ME, Sarachana T, et al. Expression Profiling of Lymphoblasts from autistic and nonaffected sib pairs: Altered pathways in neuronal development and steroid biosynthesis. Gene PLoS ONE. 2009;4(6):e5775.
5. O'Roak BJ, Vives L, Girirajan S, Karakoc E, Lee C, Smith JD, et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature. 2012;485(7397):246-250.
6. Guilmatre A, Dubourg C, Mosca AL, Legallic S, Goldenberg A, et al. Recurrent rearrangements in synaptic and neurodevelopmental genes and shared biologic pathways in schizophrenia, autism, and mental retardation. Arch Gen Psychiatry. 2009;66(9):947-56.
7. Veenstra-VanderWeele J, Blakely RD. Networking in autism: leveraging genetic, biomarker and model system findings in the search for new treatments. Neuropsychopharmacology. 2012;37(1):196-212.
8. Neale BM, Kou Y, Stevens L, Wang LS, Makarov V, Polak P. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature. 2012;485(7397):242-5.
9. Hartley SL, Seltzer MM, Abbeduto JL. Cortisol response to behavior problems in FMR1 premutation mothers of adolescents and adults with fragile X syndrome: A diathesis-stress model. Int J Behav Dev. 2012;36(1):53-61.
10. Ngounou Wetie AG, Sokolowska I, Wormwood KL, Beglinger K, Michel TM, Thome J, et al. Mass spectrometry for the detection of potential psychiatric biomarkers. J Mol. Psychiatry. 2013;1(1):8.
11. Corbett BA, Kantor AB, Schulman H, Walker WL, Lit L, Ashwood P, et al. A proteomic study of serum from children with autism showing differential expression of apolipoproteins and complement proteins. Mol Psychiatry. 2007;12(3):292-306.
12. Woods AG, Sokolowska I, Taurines R, Gerlach M, Dudley E, Thome J, et al. Potential biomarkers in psychiatry: focus on the cholesterol system. J Cell Mol Med. 2012;16(6):1184-95.
13. Ngounou Wetie AG, Wormwood K, Thome J, Dudley E, Taurines R, Gerlach M, et al. A pilot proteomic study of protein markers in autism spectrum disorder. Electrophoresis. 2014;35(14):2046-54.
14. Eichler EE, Zimmerman AW. A hot spot of genetic instability in autism. N Engl J Med. 2008;358(7):737-9.
15. Elamin NE, Al-Ayadhi LY. Brain autoantibodies in autism spectrum disorder. Biomark Med. 2014;8(3):345-52.
16. Kaysheva AL, Ivanov YD, Zgoda VG, Frantsuzov PA, Pleshakova TO, Krokhin NV, et al. Visualization and identification of hepatitis C viral particles by atomic force microscopy combined with MS/MS analysis. Biomedical chemistry. 2010;56(1): 26-39. (In Russian).
17. Ivanov YD, Kaysheva AL, Frantsuzov PA, Pleshakova TO, Krohin NV, et al. Detection of hepatitis C virus core protein in serum by atomic force microscopy combined with mass spectrometry. Int J Nanomedicine. 2015;10:1597-608.
18. Kopylov AT, Zgoda VG, Lisitsa AV, Archakov AI. Combined use of irreversible binding and MRM technology for low-and ultralow copy-number protein detection and quantitation. Proteomics. 2013;13(5):727-42.
19. Ivanov YD, Pleshakova T, Malsagova K, Kozlov A, Kaysheva A, et al. Highly sensitive protein detection by combination of atomic force microscopy fishing with charge generation and mass spectrometry analysis. FEBS J. 2014; 281(20):4705-17.
20. Kaysheva AL, Ivanov YD, Frantsuzov PA, Krohin NV, Pavlova TI, et al. Mass spectrometric detection of the amino acid sequence polymorphism of the hepatitis C virus antigen. J Virol Methods. 2016;229:86-90.
21. Ivanov YD, Bukharina NS, Pleshakova TO, Frantsuzov PA, Andreeva EY. Atomic force microscopy fishing and mass spectrometry identification of gp120 on immobilized aptamers. Int J Nanomedicine. 2014;9:4659-4670.
22. Anderson L, Anderson NG. High resolution two-dimensional electrophoresis of human plasma proteins. Proc. Nat. Acad. Sci. 1977;74(12):5421-5425.
23. Semple SJ, Smith LL, McKune AJ, Hoyos J, Mokgethwa B, et al. Serum concentrations of C reactive protein, alpha1 antitrypsin, and complement (C3, C4, C1 esterase inhibitor) before and during the Vuelta a Espana. Br J Sports Med. 2006;40(2):124-7.